MiR-145 participates in the development of lupus nephritis by targeting CSF1 to regulate the JAK/STAT signaling pathway. (June 2022)

• Record Type: Journal Article
• Authors: Liao, Wang; He, Xiao-Jie; Zhang, Wei; Chen, Ye-Li; Yang, Jie; Xiang, Wei; Ding, Yan
• Is Part Of: Cytokine. Volume 154(2022)
• Publication Date: 2022-06
• Subjects: Lupus nephritis -- miR-145 -- CSF1 -- JAK/STAT signaling pathway; CSF1 colony stimulating factor-1 -- ELISA enzyme linked immunosorbent assay -- HE staining Hematoxylin and eosin HE staining -- HRMCS human renal mesangial cells -- IL interleukin -- LPS lipopolysaccharide -- LN lupus nephritis -- miRNAs microRNAs -- SLE systemic lupus erythematosus -- TNF tumor necrosis factor; Cytokines -- Periodicals; 571.844
• DOI: 10.1016/j.cyto.2022.155877
• Languages: English
• ISSNs: 1043-4666

Abstract

Abstract: Background: Lupus nephritis (LN) is a chronic autoimmune disease, leading to progressive renal dysfunction. MicroRNAs (miRNAs) contribute to LN pathophysiology. Nevertheless, the potential mechanisms of miR-145 in LN remain unclear. Here, we investigated the contribution of miR-145 to LN progression. Methods: qRT-PCR analysis determined miR-145 and CSF1 expression. Western blot tested CSF1, JAK2, p-JAK2, STAT3, p-STAT3, cleaved caspase3, Bax and Bcl-2 expression. Dual luciferase reporter assay confirmed the interaction between miR-145 and CSF1. ELISA assay detected the secretion of inflammatory molecules. Flow cytometric analysis determined cell cycle and apoptosis. MTT was conducted to test cell viability. The LN mouse model was constructed for in vivo experiments. HE and Masson staining examined the kidney pathologic changes. Results: MiR-145 was down-regulated in LN patients and LPS-induced HRMCS, whereas CSF1 was up-regulated. Moreover, miR-145 overexpression inhibited HRMCS cell apoptosis and inflammatory damage. Besides, miR-145 was found to directly target CSF1. Additionally, knockdown of CSF1 inhibited HRMCS cell apoptosis and inflammatory damage by inactivating the JAK/STAT signaling pathway. Furthermore, miR-145 inhibited inflammatory damage and cell apoptosis of HRMCS by down-regulating CSF1. Finally, we verified that miR-145 suppressed LN development in vivo. Conclusion: Our data reveals that miR-145 regulates LN progression via CSF1 mediated JAK/STAT signaling pathway, and miR-145 may be a new therapeutic target for LN treatment.